Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
By Justice Department, Drug Enforcement Administration · Nov 9, 2026, 11:00 PM CST
The Drug Enforcement Administration (DEA) proposes to establish the 2027 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Excerpt shown under fair-use limits. Full text remains with the original publisher.
Layer 1 · Claims & fact checks
AI analysisContext
AI analysisMissing context
The article does not explain the reasons for the DEA's proposal, the process for setting production quotas, potential impacts on medical, scientific, or law‑enforcement communities, or any public comment period or stakeholder input.
Important context
Understanding the DEA's role in regulating controlled substances and the significance of production quotas for Schedule I and II drugs, as well as the importance of list I chemicals in the manufacture of certain pharmaceuticals, would provide necessary background for readers.
Opinion vs. reporting
AI analysisThe piece presents factual information about a DEA proposal without offering analysis, interpretation, or opinion; it is purely reporting.